Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Craig Rogers who wrote (9006)	6/3/1998 11:42:00 AM
From: Frostman	Read Replies (1) \| Respond to of 23519

Craig, The Genesis annct is not good, but has not driven the price down. The annct came out at about 10:51A. Five of six of the ED type stocks are down today, ZONA especially. 11:50am, one hour after Genesis annct, VVUS 7 13/16, trading 1/8 off of open with over 2M shares traded. Jeeze, I remember when 27 seemed low. VVUS 11:18AM 7 13/16 -15/16 -10.71% 1,939,100 PFE 11:14AM 104 3/8 -55/256 -0.21% 1,197,100 ZONA 11:18AM 32 3/4 -4 -10.88% 566,700 ICOS 11:19AM 18 7/8 -5/8 -3.21% 746,800 SNTKY 11:07AM 4 5/32 +3/32 +2.31% 39,700 MCHM 11:18AM 10 5/8 -3/4 -6.59% 378,500

To: Craig Rogers who wrote (9006)	6/3/1998 12:12:00 PM
From: Tunica Albuginea	Read Replies (2) \| Respond to of 23519

Craig, Genesis downgrade is based on the AUA abstracts. My reply to Genesis is to do their homework by reading Message 4702626 Also, it has been speculated that the brokerage houses are the Vivus shorts. So if we assume ( hypothetically of course, GG ) that Genesis is shorting Vivus by selling stock that they own ( something illegal of course, and this is why VLAD is in touch with the SEC ), then this is what the brokerage houses would do. Also I believe that they are now buying Vivus, for them to upgrade later after they bought it, TA

To: Craig Rogers who wrote (9006)	6/3/1998 12:47:00 PM
From: 4 - Bob	Respond to of 23519

Yep, another one jumps on the bandwagon. These studies, reports, downgrades, articles, newswires, earnings revisions, etc. are short term successful in depressing the price of VVUS shares even further. Supporters of Muse concede that an oral delivery has greater popularity than its delivery method. With the recent focus on safety, attention is being diverted by attempting to discredit Muse in its effectiveness. More time and observation is needed before the real picture emerges. One should do their own DD in evaluating these reports. Having nerves of steel and ice water running through your veins will also help if today's price movement has got you uneasy. <ggg> Live Long & Prosper, 4-Bob